TD001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TD001, covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer [Phase 1, Phase 2]